ASCO GU 2026: Updates in metastatic prostate cancer
Prof Christina Fotopoulou talks to ecancer at the Ovacome Member's Day 2019 about the value of surgery in ovarian cancer.
She outlines the importance of a need for extra expertise in specialised cancer centres due to the individual nature of the disease.
Prof Fotopoulou also discusses the situations where it could be advisable not to undergo surgery and also the complications of operations compared with other treatments.
ASCO GU 2026: Updates in metastatic prostate cancer
ASCO GU 2026: Updates in localised prostate cancer
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer
2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
OncoAlert Round Up for September 15-21, 2023